Cystatin C Measurement
J15 · Effective Dec 17, 2018
21 active Medicare policies list 82610, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Dec 17, 2018
J9 · Effective Feb 2, 2018
JE · Effective Feb 11, 2019
JF · Effective Feb 11, 2019
JJ · Effective Dec 3, 2018
JM · Effective Dec 3, 2018
J15 · Effective Oct 5, 2015
JE · Effective Jun 1, 2016
JF · Effective Jun 1, 2016
5 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 82610 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
| Policy | Effective | Status of 82610 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
| Policy | Effective | Status of 82610 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 |
JJ · Effective Oct 5, 2015
JM · Effective Oct 5, 2015
J5 · Effective Jun 16, 2016
J8 · Effective Jun 16, 2016
National · Effective Dec 4, 2025
J9 · Effective Oct 1, 2020
National · Effective Oct 1, 2026
National · Effective Sep 11, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
| Covered |
| Policy | Effective | Status of 82610 |
|---|---|---|
| Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | Jul 15, 2026 | Covered |
| Policy | Effective | Status of 82610 |
|---|---|---|
| Preventive Care Services | Sep 1, 2026 | Covered |